Overall, the combined metabolic, neurochemical, and immunomodulatory effects of GLP-1 RAs suggest they could offer therapeutic benefits in mood disorders, especially for patients with coexisting metabolic dysfunction or resistance to standard treatments [15,19,20]. This evidence concerns the gene GCG and mood disorder.